JPS5855421A - 医薬組成物 - Google Patents

医薬組成物

Info

Publication number
JPS5855421A
JPS5855421A JP57153790A JP15379082A JPS5855421A JP S5855421 A JPS5855421 A JP S5855421A JP 57153790 A JP57153790 A JP 57153790A JP 15379082 A JP15379082 A JP 15379082A JP S5855421 A JPS5855421 A JP S5855421A
Authority
JP
Japan
Prior art keywords
methanol
phenoxy
methyl
propyl
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP57153790A
Other languages
English (en)
Japanese (ja)
Inventor
ロイ・ト−マス・ブリツテン
バリ−・ジヨン・プライス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of JPS5855421A publication Critical patent/JPS5855421A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP57153790A 1981-09-04 1982-09-03 医薬組成物 Pending JPS5855421A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8126787 1981-09-04
GB26787 1981-09-04

Publications (1)

Publication Number Publication Date
JPS5855421A true JPS5855421A (ja) 1983-04-01

Family

ID=10524317

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57153790A Pending JPS5855421A (ja) 1981-09-04 1982-09-03 医薬組成物

Country Status (18)

Country Link
JP (1) JPS5855421A (it)
KR (1) KR840001276A (it)
AU (1) AU8799882A (it)
BE (1) BE894286A (it)
DE (1) DE3232831A1 (it)
DK (1) DK396582A (it)
FI (1) FI823041L (it)
FR (1) FR2512343A1 (it)
GB (1) GB2105588B (it)
GR (1) GR76433B (it)
IL (1) IL66709A0 (it)
IT (1) IT8249072A0 (it)
LU (1) LU84364A1 (it)
NL (1) NL8203456A (it)
PT (1) PT75504A (it)
SE (1) SE8205035L (it)
ZA (1) ZA826479B (it)
ZW (1) ZW18582A1 (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010064441A1 (ja) * 2008-12-04 2010-06-10 株式会社ネクスト21 NSAIDs誘発性消化管粘膜障害軽減剤及びその製造方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567179A (en) * 1984-10-11 1986-01-28 Pfizer, Inc. Antiinflammatory salts of piroxicam
US4636498A (en) * 1984-10-11 1987-01-13 Pfizer Inc. Formulation of antiinflammatory drugs
GB8805268D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3067920D1 (en) * 1979-03-02 1984-06-28 Glaxo Group Ltd 1,2,4-triazole derivatives, processes for their production and pharmaceutical compositions containing them
US4410523A (en) * 1979-10-22 1983-10-18 Glaxo Group Limited Heterocyclic derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010064441A1 (ja) * 2008-12-04 2010-06-10 株式会社ネクスト21 NSAIDs誘発性消化管粘膜障害軽減剤及びその製造方法
CN102238964A (zh) * 2008-12-04 2011-11-09 21世纪国际新技术株式会社 NSAIDs诱因消化道粘膜损伤抑制剂及其制造方法

Also Published As

Publication number Publication date
DE3232831A1 (de) 1983-03-24
FR2512343A1 (fr) 1983-03-11
IT8249072A0 (it) 1982-09-03
GB2105588A (en) 1983-03-30
GR76433B (it) 1984-08-10
AU8799882A (en) 1983-03-10
BE894286A (fr) 1983-03-02
PT75504A (en) 1982-10-01
FI823041A7 (fi) 1983-03-05
FI823041A0 (fi) 1982-09-03
IL66709A0 (en) 1982-12-31
SE8205035L (sv) 1983-03-05
KR840001276A (ko) 1984-04-30
LU84364A1 (fr) 1984-04-24
NL8203456A (nl) 1983-04-05
DK396582A (da) 1983-03-05
ZA826479B (en) 1984-04-25
ZW18582A1 (en) 1984-03-28
FI823041L (fi) 1983-03-05
SE8205035D0 (sv) 1982-09-03
GB2105588B (en) 1984-07-18

Similar Documents

Publication Publication Date Title
US5466436A (en) Medicaments for treating inflammatory conditions or for analgesia
JPS63198623A (ja) 医薬組成物
CY1398A (en) Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
IE51549B1 (en) Solid medicament formulations containing nifedipine,and processes for their preparation
JPH06502854A (ja) 老年痴呆、過食症、片頭痛または食欲不振の治療用のパロキセチンの使用
WO2000010537A1 (en) Timed release tablet comprising naproxen and pseudoephedrine
CZ287558B6 (en) Pharmaceutical preparation
RU2002123182A (ru) Содержащая ибупрофен композиция
CA2211325A1 (en) Extended release clonidine formulation
JP2006515299A5 (it)
JPS6357405B2 (it)
HU186855B (en) Process for producing galenic pharmaceutical compositions with controlled solving-out of active agents
EP0109281A1 (en) Compositions comprising flurbiprofen or ibuprofen
JPS5896036A (ja) 新ナフタレン誘導体の製法
JPS5855421A (ja) 医薬組成物
JPS6191124A (ja) 抗炎症組成物
CA1307739C (en) Anti-inflammatory compositions
JP3982889B2 (ja) イブプロフェン含有医薬製剤
US4083950A (en) Stable acetylsalicylic acid and phenylpropanolamine salt composition
EP0012621B1 (en) Analgesic composition comprising acetaminophen as a potentiating agent
JPS5865215A (ja) 医薬組成物
GB2216413A (en) Medicaments containing sufotidine
RU2134579C1 (ru) Лекарственные средства для лечения воспалительных состояний или для анальгезии
US3900566A (en) Pharmaceutical compositions containing the tert butyl ester of n-((1-carboxy-l-prolyl)-oxy)-succinimide and method of use
JPS595192A (ja) カルボン酸誘導体